Breaking News

Sartorius Launches New Services for Mammalian Cell Bank Manufacture

Combines services for cell line development, cell bank manufacturing, and cell bank characterization

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sartorius Stedim Biotech (SSB) has launched new services for mammalian cell bank manufacture under GMP conditions. The services are offered by its subsidiary, Sartorius Stedim BioOutsource, a contract testing organization (CTO) based in Glasgow, UK, and in Cambridge, MA, USA.   The new services cover the manufacture of GMP master and working cell banks (MCB/WCB) for mammalian suspension cells, conducted in a custom-designed 260 m2 GMP cleanroom facility that has been audited and approved in 20...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters